Showing results (2231-2240 of 2,577) with videos related to
Sort By:
Pageof 258
Journal of Medicinal Chemistry|May 25, 2013
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitorsHoward Bregman, Nagasree Chakka, Angel Guzman-Perez, et al.Journal of the National Cancer Institute|September 29, 2022
DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancerHuichuan Yu, Xiaolin Wang, Liangliang Bai, et al.Plos One|July 23, 2025
Magnetic resonance evaluation of three-dimensional liver fat fraction by hepatitis C status and associations with inflammatory cytokinesJessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.Bioorganic & Medicinal Chemistry Letters|February 7, 2007
Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SARErin F DiMauro, John Newcomb, Joseph J Nunes, et al.BMJ (Clinical Research Ed.)|July 7, 2009
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort studyJohn H Kempen, Ebenezer Daniel, James P Dunn, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family RegistryJenny N Poynter, Elizabeth T Jacobs, Jane C Figueiredo, et al.The Journal of Thoracic and Cardiovascular Surgery|February 19, 2013
Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: a propensity-matched comparisonAndrew B Goldstone, Pavan Atluri, Wilson Y Szeto, et al.Journal of Medicinal Chemistry|January 5, 2021
Discovery of Potent and Selective Methylenephosphonic Acid CD73 InhibitorsEhesan U Sharif, Jaroslaw Kalisiak, Kenneth V Lawson, et al.Hemasphere|November 15, 2024
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myelomaWassilis S C Bruins, Rosa Rentenaar, John Newcomb, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2010
Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family RegistryRebecca S Holmes, Yingye Zheng, John A Baron, et al.Pageof 258